Bell AH-1Z/UH-1Y Fleet Passes 400,000 Flight Hour Milestone

Image: U.S. Navy/Mass Communication Specialist 2nd Class Heath Zeigler
Gemini Sparkle

Key Takeaways:

  • Bell Textron announced its AH-1Z Viper and UH-1Y Venom helicopter fleet has accumulated over 400,000 flight hours since deployment in 2010.
  • These helicopters are the result of a 1996 U.S. Marine Corps upgrade program and are projected to remain in service into the 2040s.
  • The AH-1Z provides attack and reconnaissance capabilities, while the UH-1Y offers utility and support functions, with both models sharing 85% common major systems for sea and land operations.
See a mistake? Contact us.

Bell Textron announced on Thursday that the fleet of AH-1Z Viper and UH-1Y Venom attack and utility helicopters has passed the 400,000-flight-hour mark. The aircraft, which have been deployed for military operations since 2010, are the result of an upgrade program for H-1 helicopters launched by the U.S. Marine Corps in 1996. The Marine Corps AH-1Zs and UH-1Ys are expected to remain in service into the 2040s.

“Reaching the 400,000-hour milestone represents the collective efforts of the men and women dedicated to upholding the H-1’s legacy of success,” said Mike Deslatte, Bell H-1 vice president and program director. “The AH-1Z and UH-1Y program exemplifies the vital cooperation between industry and program to ensure we maintain an overwhelming competitive edge against future enemies.”

According to Bell, production of Marine Corps Vipers and Venoms will continue through 2022. The AH-1Z is capable of attack, aerial reconnaissance and escort missions while the UH-1Y provides functions such as battlefield resupply, troop inserts and close air support. Designed for both sea- and land-based operations, the models have 85 percent of their major systems and parts in common.

Kate O'Connor

Kate is a private pilot, certificated aircraft dispatcher, and graduate of Embry-Riddle Aeronautical University.
Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Please support AVweb.

It looks like you’re using an ad blocker. Ads keep AVweb free and fund our reporting.
Please whitelist AVweb or continue with ads enabled.